Page 29 - 中国药房2021年11期
P. 29

spectives on nonalcoholic fatty liver disease and nonalco-  Smads,NF-κ B and ERK signaling pathways[J]. Biomed
             holic steatohepatitis[J]. Hepatology,2019,69(6):2672-  Pharmacother,2019,115:108901.
             2682.                                         [18]  秦阳,高颖,高英,等.桑白皮黄酮提取物对2型糖尿病大
        [ 5 ]  KIM D,TOUROS A,KIM W R. Nonalcoholic fatty liver  鼠非酒精性脂肪肝血管生成相关基因的影响[J].中国实
             disease and metabolic syndrome[J]. Clin Liver Dis,2018,  验方剂学杂志,2017,23(17):144-148.
             22(1):133-140.                                [19]  郭亮,汤其群.非酒精性脂肪肝发病机制和治疗的研究进
        [ 6 ]  ZHAO W,SONG F,HU D,et al. The protective effect of  展[J].生命科学,2018,30(11):1165-1172.
             Myristica fragrans Houtt. extracts against obesity and in-  [20]  张学峰,杨光旭,朱友,等. NAFLD 对大鼠葡萄糖、胰岛
             flammation by regulating free fatty acids metabolism in  素代谢和肝糖原合成的影响[J].东南大学学报(医学
             nonalcoholic fatty liver disease[J]. Nutrients,2020,12  版),2020,39(4):420-424.
            (9):2507.                                      [21]  唐外姣,姚育法,殷锦锦,等.护肝清脂片对非酒精性脂肪
        [ 7 ]  赵梓铭,武俊紫,姚政,等.决明子蒽醌苷通过降低Toll样                     肝模型大鼠肝脏蛋白质合成及胆汁代谢的影响[J].中药
             受体4和核因子-κB的表达对非酒精性脂肪肝病大鼠的                          材,2014,37(8):1452-1454.
             影响[J].中国临床药理学杂志,2019,35(22):2863-2867.        [22]  ZHENG F,CAI Y. Concurrent exercise improves insulin
        [ 8 ]  XU X,WANG W,LIN L,et al. Liraglutide in combination  resistance and nonalcoholic fatty liver disease by upregu-
             with human umbilical cord mesenchymal stem cell could  lating PPAR-γ and genes involved in the beta-oxidation of
             improve liver lesions by modulating TLR4/NF-κB inflam-  fatty acids in ApoE-KO mice fed a high-fat diet[J]. Lipids
             matory pathway and oxidative stress in T2DM/NAFLD  Health Dis,2019,18(1):6.
             rats[J]. Tissue Cell,2020,66:101382.          [23]  李新征,陈宝炳,康云平.非酒精性脂肪肝患者血清游离
        [ 9 ]  肖阳,侯云鹤,尹鑫,等.人参皂苷Rg1干预非酒精性脂肪                      脂肪酸与胰岛素抵抗的关系[J].检验医学,2012,27(1):
             肝模型大鼠肝细胞的凋亡[J].中国组织工程研究,2019,                      48-49.
             23(3):384-390.                                [24]  李利阳,杨蕾.非酒精性脂肪肝与胰岛素抵抗的关系[J].
        [10]  孙晓红,李洪涛,李嘉仪,等.中性粒细胞凋亡与炎症损伤                        医学综述,2011,17(18):2840-2842.
             的关系[J].中国免疫学杂志,2017,33(12):1907-1910.         [25]  马燕花,杨少军,白洲霞,等.慈菇消脂丸对NF-κB介导的
        [11]  祁平,樊惠,刘林,等. 4-羟基苯并噁唑-2-酮对四氯化碳                     非酒精性脂肪肝病大鼠肝细胞凋亡的干预作用[J].北京
             致小鼠急性肝损伤保护作用[J].蛇志,2012,24(1):5-7,                 中医药大学学报,2017,40(10):856-863.
             10.                                           [26]  李阳,舒德军,彭慈军,等.促红细胞生成素对脂肪肝大鼠
        [12]  赵丹,于蕾,程守前,等.红树植物老鼠簕根化学成分的研                        模型肝脏缺血再灌注损伤凋亡基因bcl-2、bax mRNA表
             究[J].广东化工,2015,42(18):24-25.                       达的影响[J].临床肝胆病杂志,2019,35(1):157-160.
        [13]  王红园,韦秀桂,孙雪梅,等.老鼠簕生物碱A对D-GalN/                [27]  ZHU J,ZHOU M,ZHAO X,et al. Blueberry,combined
             LPS 致小鼠急性肝损伤的影响[J].中药材,2019,42(9):                 with probiotics,alleviates non-alcoholic fatty liver disease
             2177-2180.                                         via IL-22-mediated JAK1/STAT3/BAX signaling[J]. Food
        [14]  黄秀昆,孙雪梅,朱勋帅,等. 4-羟基苯并噁唑-2-酮对四                     Funct,2018,9(12):6298-6306.
             氯化碳诱导大鼠肝纤维化的改善作用及机制研究[J].中                    [28]  SHIFFMAN M,FREILICH B,VUPPALANCHI R,et al.
             国药房,2019,30(6):747-751.                            Randomised clinical trial:emricasan versus placebo signi-
        [15]  WANG D,LAO L,PANG X,et al. Asiatic acid from Po-  ficantly decreases ALT and caspase 3/7 activation in sub-
             tentilla chinensis alleviates non-alcoholic fatty liver by  jects with non-alcoholic fatty liver disease[J]. Aliment
             regulating endoplasmic reticulum stress and lipid metabo-  Pharmacol Ther,2019,49(1):64-73.
             lism[J]. IntImmunopharmacol,2018,65:256-267.  [29]  杨海峰,薛玲,郑彩娟,等. Caspase-3在慢性病毒性乙、丙
        [16]  廖媛,池晓玲,吴宇金,等.脂必泰对非酒精性脂肪肝病大                        型肝炎及非酒精性肝炎中的表达及意义[J].世界华人消
             鼠模型疗效评价[J].中国医院药学杂志,2020,40(22):                   化杂志,2012,20(36):3701-3706.
             2317-2321,2326.                                              (收稿日期:2021-01-09  修回日期:2021-03-27)
        [17]  SUN X,HUANG X,ZHU X,et al. HBOA ameliorates                                       (编辑:唐晓莲)
             CCl 4-induced liver fibrosis through inhibiting TGF-β1/












        中国药房    2021年第32卷第11期                                             China Pharmacy 2021 Vol. 32 No. 11  ·1303 ·
   24   25   26   27   28   29   30   31   32   33   34